The Cancer Institute Hospital of JFCR

Kōtō City 135-8550

5 studies enrolling now · 8 studies all time

What they study most

Advanced Solid Tumor, Bladder Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Cervical Cancer, Distal Sensory Polyneuropathy, Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Solid Tumor, Neuropathic Pain, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
• A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors — Recruiting now
• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors — Recruiting now
• First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors — Recruiting now
• Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy — Completed
• A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors — Running, not enrolling
• Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling